All In MedTech

Device Trial Radar · NCT05912556

Brain Response to an Intervention Using Guided, At-Home Technology for the Mind

Brain Response to an Intervention Using Guided, At-Home Technology for the Mind - A Randomized, Controlled, Double-blinded, Parallel-group Intervention Study to Assess an At-Home Program for Improving Cognition and Inducing Changes in Brain Structure and Function

Last checked: Nov 20, 2026Latest source record: Sep 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 817 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

817

Actual

Start

Jul 17, 2023

Primary completion

Mar 11, 2025

Study completion Mar 11, 2025

Sponsor

Lead sponsor
Lumos Labs, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Jun 22, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 25 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objective of this study is to assess the effectiveness of two digital programs for providing mental stimulation, improving cognition, and inducing changes in brain structure and function.

Conditions

  • Cognition
  • Brain Health
  • Brain Structure
  • Brain Function

Interventions

  • Digital Program 1Device

    2/3 of randomized subjects use digital program 1 for 12 weeks to provide mental stimulation

  • Digital Program 2Device

    1/3 of randomized subjects use digital program 2 for 12 weeks to provide mental stimulation

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Composite from Creyos (formerly Cambridge Brain Sciences)Time frame: Study Day 0 to Study Day 84

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Lumos Labs, Inc.

    San Francisco, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.